Exploring Diroximel Fumarate Real-world Experience in Canada and Israel

TerminatedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

April 14, 2023

Study Completion Date

April 14, 2023

Conditions

Relapsing Forms of MS

Interventions

DRUG

Diroximel Fumarate

Administered as specified in the treatment arm.

Trial Locations (6)

Lady Davis Carmel Medical Center, Haifa

Hadassah Medical Center, Jerusalem

Meir Medical Center, Kfar Saba

Rabin Medical Center, Petah Tikva

Tel Aviv Sourasky Medical, Tel Aviv

Sheba Medical Center, Tel Litwinsky